Abstract
Introduction and hypothesis
Glycosaminoglycan hyaluronic acid (HA) and chondroitin sulphate (CS) protect the urothelium. Damage to the urothelium may increase bacterial adherence and infection risk. This meta-analysis evaluated the effect of intravesical HA and HA and CS (HA-CS) combination therapy in recurrent bacterial cystitis (RBC) in adult women.
Methods
A systematic literature search was performed. Primary outcomes were urinary tract infection (UTI) rate per patient-year, and UTI recurrence time (days). Secondary outcomes were 3-day voids and Pelvic Pain and Urgency/Frequency (PUF) symptom scale total score.
Results
Four studies involving a total of 143 patients were retrieved and assessed in this analysis. Two were randomized, and two were nonrandomized. A significantly decreased UTI rate per patient-year [mean difference (MD) −3.41, 95 % confidence interval (CI) −4.33 to −2.49, p < 0.00001) was found. Similarly, pooled analysis showed a significantly longer mean UTI recurrence time (days) using either HA or HA-CS therapy (MD 187.35, 95 % CI 94.33–280.37, p < 0.0001). Two studies using HA and HA-CS therapy reported outcomes on 3-day voids, which were not significantly improved after therapy (MD −3.59, 95 % CI −8.43–1.25, p = 0.15), but a significantly better PUF total score (MD −7.17, 95 % CI −9.86 to −4.48, p < 0.00001) was detected in HA-CS groups.
Conclusions
Intravesical HA and HA-CS in combination significantly reduced cystitis recurrence, mean UTI recurrence time, and PUF total score. Study limitations include the small number of patients and possible bias. Further studies are needed to validate this promising treatment modality.
Similar content being viewed by others
References
Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity and economic costs. Am J Med 113:5S–13S
Ronald A (2002) The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113:14S–9S
Chung A, Arianayagam M, Rashid P (2010) Bacterial cystitis in women. Aust Fam Physician 39(5):295–298
Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P et al (2000) Risk factors for second urinary tract infection among college women. Am J Epidemiol 151:1194–1205
Avorn J, Monane M, Gurwitz JH et al (1992) Reduction of bacteriuria and pyuria after ingestion of cranberry juice. J Am Med Assoc 271:751–754
Raz R, Stamm WE (1993) A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 329:753–756
Reid G (1999) The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol 65:3763–3766
Schulman CC, Corbusier A, Michiels H et al (1993) Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. J Urol 150:917–921
Kruze D, Holzbecher K, Andrial M et al (1989) Urinary antibody response after immunisation with a vaccine against urinary tract infection. Urol Res 17:361–366
Mulvey MA, Lopez-Boado YS, Wilson CL et al (1999) Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282:1494–1497
Schilling JD, Mulvey MA, Hultgren SJ (2001) Dynamic interactions between host and pathogen during acute urinary tract infections. Urology 57:56–61
Poggi MM, Johnstone PAS, Conner RJ (2000) Glycosaminoglycan content of human bladders: a method of analysis using coldcup biopsies. Urol Oncol 5:234–237
Morales A, Emerson L, Nickel JC (1997) Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. Urology 49:111–113
Parsons CL (1997) Epithelial coating techniques in the treatment of interstitial cystitis. Urology 49:100–104
Daha LK, Riedl CR, Hohlbrugger G et al (2003) Comparative assessment of maximal bladder capacity, 0.9 % NaCl versus 0.2 M KCl, for diagnosis of interstitial cystitis: prospective controlled study. J Urol 170:807–809
Shao Y, Shen ZJ, Rui WB et al (2010) Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis. Urology 75(3):547–550
Porru D, Leva F, Parmigiani A, et al. (2011) Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis. Int Urogynecol J in press (PMID:21904840)
Constantinides C, Manousakas T, Nikolopoulos P et al (2004) Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study. BJU Int 93(9):1262–1266
Lipovac M, Kurz C, Reithmayr F et al (2007) Prevention of recurrent bacterial urinary tract infections by intravesical instillation of hyaluronic acid. Int J Gynaecol Obstet 96(3):192–195
De Vita D, Giordano S (2012) Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: randomized study. Int Urogynecol J in press (PMID:22614285)
Moher D, Liberati A, Tetzlaff J et al (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336–41
Haylen BT, de Ridder D, Freeman RM et al (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21:5–26
Ito T, Tomoe H, Ueda T, Yoshimura N et al (2003) Clinical symptoms scale for interstitial cystitis for diagnosis and for following the course of the disease. Int J Urol 10:S24–26
Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1–12
Furukawa TA, Barbui C, Cipriani A et al (2006) Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 59(1):7–10
Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 20;5:13
Stevens JW (2011) A note on dealing with missing standard errors in meta-analyses of continuous outcome measures in WinBUGS. Pharm Stat 10(4):374–8
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748
Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–60
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–88
Damiano R, Quarto G, Bava I et al (2011) Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial. Eur Urol 59(4):645–651
Leppilahti M, Hellström P, Tammela TL (2002) Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology 60(1):46–51
Lee DG, Cho JJ, Park HK et al (2010) Preventive effects of hyaluronic acid on Escherichia coli-induced urinary tract infection in rat. Urology 75(4):949–954
Tajana G (2009) Fisiopatologia clinica e biologia dell’urotelio. Minerva Uroll Nefrol 61(3):1–31
Fraser MO, Lavelle JP, Sacks MS et al (2002) The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy. Rev Urol 4(1):1–11
Schulz A, Vestweber AM, Dressler D (2009) Anti-inflammatory action of a hyaluronic acid-chondroitin sulfate preparation in an in vitro bladder model. Aktuelle Urol 40(2):109–12
Southgate J, Varley CL, Garthwaite MA et al (2007) Differentiation potential of urothelium from patients with benign bladder dysfunction. BJU Int 99(6):1506–1516
Engelhardt PF, Morakis N, Daha LK et al (2010) Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 22(4):401–405
Hooton TM (2001) Recurrent urinary tract infection in women. Int J Antimicrob Agents 17:259–268
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
De Vita, D., Antell, H. & Giordano, S. Effectiveness of intravesical hyaluronic acid with or without chondroitin sulfate for recurrent bacterial cystitis in adult women: a meta-analysis. Int Urogynecol J 24, 545–552 (2013). https://doi.org/10.1007/s00192-012-1957-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-012-1957-y